SCHEMBL21136588

SCHEMBL21136588

CC(C)N(C)C(=O)C(F)(CC1CCCCC1)S(=O)(=O)O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.33
CTSB P07858 3/20 0.33
MMP1 P03956 3/20 0.33
MMP13 P45452 3/20 0.33
CTSH P09668 2/20 0.33
MMP2 P08253 2/20 0.33
MMP3 P08254 2/20 0.33
MMP8 P22894 2/20 0.33
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
CTSK P43235 5/20 0.32
MLYCD O95822 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
NPY5R Q15761 1/20 0.30
MMP9 P14780 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21135757 0.90 MMP1 (0.33) CTSLCTSBMMP1MMP13CTSH
SCHEMBL21135706 0.83 ALDH1A1 (0.36) MMP1MMP13MMP2MMP3MMP8
SCHEMBL21135740 0.81 HDAC6 (0.32) MMP1MMP13MMP2MMP3MMP8
SCHEMBL21135976 0.79 HDAC6 (0.34) MMP1MMP13MLYCDHDAC6MMP9
SCHEMBL21135980 0.77 HDAC6 (0.33) MMP1MMP13MLYCDHDAC6MMP9
SCHEMBL21135765 0.77 CTSL (0.33) CTSLCTSBMMP1MMP13CTSH
SCHEMBL21135974 0.76 MMP1 (0.40) MMP1MMP13MMP2MMP3MLYCD
SCHEMBL21136589 0.75 CHRM2 (0.33) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL21135984 0.74 EPHX1 (0.36) MMP1MMP13MLYCDHDAC6MMP9
SCHEMBL21136591 0.72 CHRM2 (0.32) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190196326-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190196326-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE RER1, ACTR5, RAD51 CTSL 3329/4885CTSB 1634/4885MMP1 3169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.